From July 9 to 11, 2025, Tokyo welcomed INTERPHEX Week, Japan's largest pharmaceutical and biotechnology exhibition, amid the midsummer heat. As a key segment of the event, the Regenerative Medicine EXPO Tokyo attracted global industry leaders such as Thermo Fisher, Merck, and Asahi KASE, serving as a premier platform to showcase cutting-edge technologies and innovative achievements in the pharmaceutical sector.

Notably, the Regenerative Medicine EXPO Tokyo is the sister event of the Regenerative Medicine EXPO Osaka, held in February. Following its participation in the Osaka exhibition, CHEMFISH returned to the Tokyo show, presenting high-end pharmaceutical intermediates and material chemical products to carve out a distinct niche with its unique product lineup.

During the exhibition, CHEMFISH reaped substantial gains. Beyond gathering valuable product insights, the company strengthened long-standing partnerships through face-to-face meetings with existing clients and expanded its market reach by forging connections with new customers. Leveraging its resource advantages.

The Tokyo INTERPHEX Week provided CHEMFISH with an exceptional platform to engage with global pharmaceutical leaders and showcase its capabilities. Through active participation, the company not only enhanced its brand visibility but also achieved tangible progress in the biopharmaceutical sector, marking a fruitful endeavor overall.